title: Covalent Modification of Bacteriophage T4 DNA Inhibits CRISPR-Cas9.
abstract: The genomic DNAs of tailed bacteriophages are commonly modified by the attachment of chemical groups. Some forms of DNA modification are known to protect phage DNA from cleavage by restriction enzymes, but others are of unknown function. Recently, the CRISPR-Cas nuclease complexes were shown to mediate bacterial adaptive immunity by RNA-guided target recognition, raising the question of whether phage DNA modifications may also block attack by CRISPR-Cas9. We investigated phage T4 as a model system, where cytosine is replaced with glucosyl-hydroxymethylcytosine (glc-HMC). We first quantified the extent and distribution of covalent modifications in T4 DNA by single-molecule DNA sequencing and enzymatic probing. We then designed CRISPR spacer sequences targeting T4 and found that wild-type T4 containing glc-HMC was insensitive to attack by CRISPR-Cas9 but mutants with unmodified cytosine were sensitive. Phage with HMC showed only intermediate sensitivity. While this work was in progress, another group reported examples of heavily engineered CRISRP-Cas9 complexes that could, in fact, overcome the effects of T4 DNA modification, indicating that modifications can inhibit but do not always fully block attack.
  
  
  OBJECTIVE
  Bacteria were recently found to have a form of adaptive immunity, the CRISPR-Cas systems, which use nucleic acid pairing to recognize and cleave genomic DNA of invaders such as bacteriophage. Historic work with tailed phages has shown that phage DNA is often modified by covalent attachment of large chemical groups. Here we demonstrate that DNA modification in phage T4 inhibits attack by the CRISPR-Cas9 system. This finding provides insight into mechanisms of host-virus competition and also a new set of tools that may be useful in modulating the activity of CRISPR-Cas9 in genome engineering applications.
authors.affiliation: Department of Microbiology, University of Pennsylvania School of Medicine, Philadelphia, Pennsylvania, USA.
authors.forename: Alexandra L
authors.initials: AL
authors.lastname: Bryson
authors.affiliation: Department of Microbiology, University of Pennsylvania School of Medicine, Philadelphia, Pennsylvania, USA.
authors.forename: Young
authors.initials: Y
authors.lastname: Hwang
authors.affiliation: Department of Microbiology, University of Pennsylvania School of Medicine, Philadelphia, Pennsylvania, USA.
authors.forename: Scott
authors.initials: S
authors.lastname: Sherrill-Mix
authors.affiliation: Division of Gastroenterology, University of Pennsylvania School of Medicine, Philadelphia, Pennsylvania, USA.
authors.forename: Gary D
authors.initials: GD
authors.lastname: Wu
authors.forename: James D
authors.initials: JD
authors.lastname: Lewis
authors.affiliation: Department of Biochemistry and Molecular Biology, University of Maryland Medical School, Baltimore, Maryland, USA.
authors.forename: Lindsay
authors.initials: L
authors.lastname: Black
authors.affiliation: Pacific Biosciences, Menlo Park, California, USA.
authors.forename: Tyson A
authors.initials: TA
authors.lastname: Clark
authors.affiliation: Department of Microbiology, University of Pennsylvania School of Medicine, Philadelphia, Pennsylvania, USA bushman@mail.med.upenn.edu.
authors.forename: Frederic D
authors.initials: FD
authors.lastname: Bushman
mesh_terms: D017122:Bacteriophage T4 / Q000235:genetics* / Q000254:growth & development*; D064113:CRISPR-Cas Systems; D003596:Cytosine / Q000737:chemistry / Q000378:metabolism; D004279:DNA, Viral / Q000737:chemistry* / Q000235:genetics / Q000378:metabolism*; D004926:Escherichia coli / Q000821:virology*; D050296:Microbial Viability; D008969:Molecular Sequence Data; D017422:Sequence Analysis, DNA; D010948:Viral Plaque Assay
chemical_list: D004279:DNA, Viral; D003596:Cytosine